{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:45:49Z","timestamp":1790232349306,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.rdc.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T03:30:39Z","timestamp":1510716639000},"page":"65-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Rheumatic Manifestations in Autoimmune Liver Disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Generali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6957","key":"10.1016\/j.rdc.2017.09.008_bib1","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjms.2016.10.014","article-title":"Lupus hepatitis and autoimmune hepatitis (lupoid hepatitis)","volume":"353","author":"Adiga","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rdc.2017.09.008_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.11.004","article-title":"Diego and Giorgina Vergani: the two hearts of translational autoimmunity","volume":"66","author":"Liberal","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-017-0345-y","article-title":"Why doesn't primary biliary cholangitis respond to immunosuppressive medications?","volume":"16","author":"Molinaro","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.rdc.2017.09.008_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","article-title":"Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece","volume":"42","author":"Gatselis","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib7","doi-asserted-by":"crossref","first-page":"e0182391","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2017.09.008_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2016.03.003","article-title":"Gender-specific incidence of autoimmune diseases from national registers","volume":"69","author":"Ji","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2017.07.003","article-title":"Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review","volume":"83","author":"Ma","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib10","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/cti.2017.14","article-title":"Diagnostic autoantibodies for autoimmune liver diseases","volume":"6","author":"Toh","year":"2017","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.rdc.2017.09.008_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","article-title":"Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity","volume":"82","author":"Watad","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"5717","key":"10.1016\/j.rdc.2017.09.008_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmj.3.5717.258","article-title":"Scleroderma and primary biliary cirrhosis","volume":"3","author":"Murray-Lyon","year":"1970","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.37.1.42","article-title":"Rheumatic disorders in primary biliary cirrhosis","volume":"37","author":"Clarke","year":"1978","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.008_bib14","first-page":"1112","article-title":"Primary biliary cirrhosis, scleroderma and keratoconjunctivitis sicca","volume":"66","author":"Morgan","year":"1973","journal-title":"Proc R Soc Med"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2017.09.008_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13317-017-0098-1","article-title":"Personalized medicine in rheumatology: the paradigm of serum autoantibodies","volume":"8","author":"Sirotti","year":"2017","journal-title":"Auto Immun Highlights"},{"issue":"9777","key":"10.1016\/j.rdc.2017.09.008_bib17","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3350\/cmh.2016.0089","article-title":"The use of immunosuppression in autoimmune hepatitis: a current literature review","volume":"23","author":"Cropley","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib20","first-page":"71","article-title":"Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjogren syndrome. Report of two cases and review of literature","volume":"9","author":"Chimenti","year":"2015","journal-title":"J\u00a0Dermatol Case Rep"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.008_bib21","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10620-016-4195-1","article-title":"Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported","volume":"61","author":"Card","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rdc.2015.08.005","article-title":"Glucocorticoid-induced osteoporosis","volume":"42","author":"Whittier","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.gtc.2016.02.009","article-title":"Metabolic bone disease in primary biliary cirrhosis","volume":"45","author":"Glass","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rdc.2017.09.008_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaut.2013.06.014","article-title":"Clinical management of autoimmune biliary diseases","volume":"46","author":"Imam","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","article-title":"The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development","volume":"78","author":"Hardtke-Wolenski","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2017.09.008_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33","author":"Jepsen","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.rdc.2017.09.008_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults - a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","article-title":"The clinical phenotypes of autoimmune hepatitis: a comprehensive review","volume":"66","author":"Wang","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","article-title":"Using GWAS to identify genetic predisposition in hepatic autoimmunity","volume":"66","author":"Webb","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib34","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2017.09.008_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Dig Dis"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.008_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/1744666X.2017.1327355","article-title":"Diagnostic approach to autoimmune hepatitis","volume":"13","author":"Muratori","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BOR.0b013e328010c56b","article-title":"Autoimmune liver disease and rheumatic manifestations","volume":"19","author":"Czaja","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2014.01.032","article-title":"Anti-TNF-induced autoimmune hepatitis","volume":"61","author":"Borman","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40264-015-0366-9","article-title":"Hepatotoxicity associated with the use of anti-TNF-alpha agents","volume":"39","author":"French","year":"2016","journal-title":"Drug Saf"},{"issue":"24","key":"10.1016\/j.rdc.2017.09.008_bib42","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: a single center report of 8 cases","volume":"21","author":"Rodrigues","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.008_bib43","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","author":"Sebode","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.rdc.2017.09.008_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib45","first-page":"222","article-title":"The importance of autoantibody detection in autoimmune hepatitis","volume":"6","author":"Cancado","year":"2015","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2017.09.008_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000440748","article-title":"Autoantibodies in autoimmune hepatitis","volume":"33","author":"Muratori","year":"2015","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0009922815588980","article-title":"Autoimmune hepatitis type 2 associated with positive antimitochondrial antibodies: an overlap syndrome?","volume":"55","author":"Mullin","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","article-title":"Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis","volume":"24","author":"Liaskos","year":"2005","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejim.2005.01.014","article-title":"Autoimmune hepatitis associated with the antiphospholipid syndrome and ulcerative colitis","volume":"16","author":"Linares","year":"2005","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib51","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0168-8278(95)80308-4","article-title":"Frequency and significance of antibodies to histones in autoimmune hepatitis","volume":"23","author":"Czaja","year":"1995","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/1744666X.2017.1319764","article-title":"Evolving paradigm of treatment for autoimmune hepatitis","volume":"13","author":"Czaja","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rdc.2017.09.008_bib55","article-title":"Methotrexate therapy for autoimmune hepatitis","author":"Haridy","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2017.09.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.06.001","article-title":"Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis","author":"Efe","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.008_bib59","first-page":"7181685","article-title":"Autoimmune hepatitis: progress from global immunosuppression to personalised regulatory T\u00a0cell therapy","volume":"2016","author":"Than","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib61","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.transproceed.2017.03.014","article-title":"Comparative analysis of the clinical outcomes of liver transplantation for probable and definite auto-immune hepatitis by international diagnostic scoring criteria","volume":"49","author":"Cho","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.rdc.2017.09.008_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2015.08.021","article-title":"An update on liver transplantation: a critical review","volume":"66","author":"Neuberger","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","article-title":"'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: a comprehensive review","volume":"66","author":"Kerkar","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib64","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.29059","article-title":"The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis","volume":"65","author":"Shuai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.rdc.2017.09.008_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","article-title":"The immunogenetics of primary biliary cirrhosis: a comprehensive review","volume":"64","author":"Webb","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib66","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.008_bib67","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.cgh.2015.08.025","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'","volume":"13","author":"Beuers","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00535-017-1333-2","article-title":"Geoepidemiology and changing mortality in primary biliary cholangitis","volume":"52","author":"Floreani","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.dld.2017.05.001","article-title":"Primary biliary cholangitis: advances in management and treatment of the disease","volume":"49","author":"Invernizzi","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2017.09.008_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6096","key":"10.1016\/j.rdc.2017.09.008_bib71","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/bmj.2.6096.1224-c","article-title":"Arthritis and primary biliary cirrhosis","volume":"2","author":"Mills","year":"1977","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/clim.1999.4690","article-title":"The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases","volume":"91","author":"Parikh-Patel","year":"1999","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib73","first-page":"708","article-title":"Enthesopathy in a case of primary biliary cirrhosis with positive HLA-B27","volume":"15","author":"Kung","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib74","first-page":"e1247","article-title":"Dermatitis herpetiformis as the initial presentation of primary biliary cholangitis in a male with gluten sensitivity","volume":"9","author":"Philips","year":"2017","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib75","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00005-016-0448-0","article-title":"Primary biliary cholangitis associated with skin disorders: a case report and review of the literature","volume":"65","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib76","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2796.1991.tb00470.x","article-title":"Features of Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"230","author":"Uddenfeldt","year":"1991","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib78","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.008_bib79","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"4\u20135","key":"10.1016\/j.rdc.2017.09.008_bib80","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2017.09.008_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinre.2013.05.002","article-title":"Autoantibodies in primary biliary cirrhosis: antimitochondrial autoantibodies","volume":"37","author":"Chantran","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.008_bib84","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.008_bib86","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0025-6196(12)62059-X","article-title":"The anticentromere antibody: disease specificity and clinical significance","volume":"59","author":"Powell","year":"1984","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.008_bib87","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies (ACA): clinical distribution and disease specificity","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15403\/jgld-1277","article-title":"Nailfold capillaroscopy in primary biliary cirrhosis: a useful tool for the early diagnosis of scleroderma","volume":"23","author":"Tovoli","year":"2014","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-017-1327-8","article-title":"High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center","volume":"19","author":"Guillen-Del Castillo","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A\u00a0comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2017.09.008_bib91","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1196\/annals.1361.043","article-title":"Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis","volume":"1051","author":"von Landenberg","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rdc.2017.09.008_bib92","article-title":"Primary biliary cholangitis: old and novel therapy","author":"Floreani","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib93","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0016-5085(99)70317-3","article-title":"Low-dose methotrexate in primary biliary cirrhosis","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib94","first-page":"112","article-title":"Tumor necrosis factor-alpha at the crossroad between rheumatoid arthritis and autoimmune cholangitis","volume":"17","author":"Selmi","year":"2015","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib95","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12891-016-1335-x","article-title":"The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report","volume":"17","author":"Del Ross","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.rdc.2017.09.008_bib96","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","article-title":"Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis","volume":"59","author":"Wang","year":"2015","journal-title":"J\u00a0Autoimmun"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.008_bib97","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.autrev.2016.07.003","article-title":"Novel therapeutics for primary biliary cholangitis: toward a disease-stage-based approach","volume":"15","author":"Mousa","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2017.09.008_bib98","first-page":"5295164","article-title":"Genetic polymorphisms of cytotoxic T-lymphocyte antigen 4 in primary biliary cholangitis: a meta-analysis","volume":"2017","author":"Yang","year":"2017","journal-title":"J\u00a0Immunol Res"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib99","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.26067","article-title":"Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis","volume":"57","author":"Dhirapong","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cld.2015.08.005","article-title":"Primary sclerosing cholangitis: multiple phenotypes, multiple approaches","volume":"20","author":"Sarkar","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"14","key":"10.1016\/j.rdc.2017.09.008_bib101","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3748\/wjg.v23.i14.2459","article-title":"Pathogenesis and clinical spectrum of primary sclerosing cholangitis","volume":"23","author":"Gidwaney","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12016-010-8221-3","article-title":"Cutting edge issues in primary sclerosing cholangitis","volume":"41","author":"Bowlus","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4\u20135","key":"10.1016\/j.rdc.2017.09.008_bib103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","article-title":"Diagnosis and classification of primary sclerosing cholangitis","volume":"13","author":"Yimam","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2017.09.008_bib104","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","author":"Palmela","year":"2017","journal-title":"Gut Liver"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.008_bib105","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib106","doi-asserted-by":"crossref","first-page":"e0169952","DOI":"10.1371\/journal.pone.0169952","article-title":"The prevalence of nonalcoholic fatty liver disease and related metabolic comorbidities was associated with age at onset of moderate to severe plaque psoriasis: a cross-sectional study","volume":"12","author":"Xu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib107","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.20305","article-title":"High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract","volume":"40","author":"Viguier","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib108","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0016-5085(94)90181-3","article-title":"Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis","volume":"107","author":"Seibold","year":"1994","journal-title":"Gastroenterology"},{"issue":"9039","key":"10.1016\/j.rdc.2017.09.008_bib109","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.rdc.2017.09.008_bib110","first-page":"2501","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib111","article-title":"Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis","author":"Saffioti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib112","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib113","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MEG.0000000000000596","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a southern Europe population focusing on new therapeutic options","volume":"28","author":"Franceschet","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.008_bib114","first-page":"659","article-title":"Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis","volume":"109","author":"Olmedo Martin","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.008_bib115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gtc.2017.01.008","article-title":"Autoimmune hepatitis overlap syndromes and liver pathology","volume":"46","author":"Czaja","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"issue":"6\u20137","key":"10.1016\/j.rdc.2017.09.008_bib116","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clinre.2011.03.007","article-title":"Management of osteoporosis in liver disease","volume":"35","author":"Guanabens","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib117","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11894-010-0166-4","article-title":"Bone disorders in chronic liver diseases","volume":"13","author":"Luxon","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib118","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980070109","article-title":"Long-term persistence of low bone density in orthotopic liver transplantation","volume":"11","author":"Giannini","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rdc.2017.09.008_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2017.05.008","article-title":"Association between primary biliary cholangitis and fracture: a meta-analysis","author":"Zhao","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.008_bib120","doi-asserted-by":"crossref","first-page":"1423462","DOI":"10.1155\/2016\/1423462","article-title":"Diagnosis and management of cirrhosis-related osteoporosis","volume":"2016","author":"Santos","year":"2016","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib121","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"AGA technical review on osteoporosis in hepatic disorders","volume":"125","author":"Leslie","year":"2003","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.008_bib122","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v3.i12.300","article-title":"Hepatic osteodystrophy: an important matter for consideration in chronic liver disease","volume":"3","author":"Lopez-Larramona","year":"2011","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.008_bib123","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","author":"Pares","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.008_bib124","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","article-title":"Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial","volume":"19","author":"Pereira","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.008_bib125","first-page":"47","article-title":"Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment","volume":"89","author":"Crippin","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.008_bib126","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/MEG.0b013e32834cd6f6","article-title":"Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease","volume":"23","author":"Yurci","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.008_bib127","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Guanabens","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.008_bib128","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","article-title":"Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Guanabens","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.008_bib129","article-title":"Bisphosphonates for steroid-induced osteoporosis","author":"Allen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"10.1016\/j.rdc.2017.09.008_bib130","doi-asserted-by":"crossref","first-page":"e3990","DOI":"10.1097\/MD.0000000000003990","article-title":"Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: a meta-analysis","volume":"95","author":"Kan","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.008_bib131","article-title":"Hormone replacement for osteoporosis in women with primary biliary cirrhosis","author":"Rudic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.008_bib132","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/liv.12153","article-title":"Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells","volume":"33","author":"Dubreuil","year":"2013","journal-title":"Liver Int"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:19Z","timestamp":1760181379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X17300790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0889857X17300790"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatic Manifestations in Autoimmune Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}